ViaDerma Inc (OTCMKTS:VDRM) Refutes the Recent Announcement by Kasten Inc. (OTCMKTS:KAST)

ViaDerma Inc (OTCMKTS:VDRM) announced that it will counter the declaration that was made by the Kasten Inc. (OTCMKTS:KAST) alleging that the rules which had been made by the federal court favored the company.

Legal Suit

The company’s legal counsel was lucky in that they were allowed to file the complaint through Steven John Keogh in the courts located in south of Dakota.

There have been several checkups in the processes which led to filing of several experimental rights on the few products including the process not undertaken.

The president of the company was quoted saying that their lawyers did a good job when it came to defending the domestic constitutional action in order to assure investors and their rights, which are pending on the production line.

He weighed on the matter when he said that the company will continue with its push when it came to defending any legal action that attempts to counter its inventions that it has achieved through hard work, sacrifice and creativity.

Company objectives

The company is highly devoted in moving on with their advancing sales in growth objectives and improve on new products to be developed in their plans for 2018 and beyond.

ViaDerma is a highly known when it comes to the trading of pharmaceutical products and is determined to bring and introduce new products into the market.

The creative and innovative technology is highly determined to improve the leadership in the pharmaceutical industry in order to help in increasing varieties especially in the therapeutic areas widely.

The company’s leading product that is Viabecline is said to have adapted an innovative methods used to deliver the style that allows the application of active ingredients in a transparent way. The technology can be applied in the products that are in existence in the medical and cosmetics market.

There was also an application that had been made such that it enables use of a combination of CBD, which had earlier been applied in the system that was filled last year. This will help in the regulation of infection and the reduction of the spread of diseases such as addiction to several drugs which is said to have adverse effects on the patient.